Cargando…
An integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells
BACKGROUND: The sex hormone estrogen (E2) is pivotal to normal mammary gland growth and differentiation and in breast carcinogenesis. In this in silico study, we examined metabolic differences between ER(+)ve breast cancer cells during E2 deprivation. METHODS: Public repositories of SAGE and MA gene...
Autores principales: | Mandal, Soma, Davie, James R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2148057/ https://www.ncbi.nlm.nih.gov/pubmed/17883861 http://dx.doi.org/10.1186/1471-2407-7-181 |
Ejemplares similares
-
Schisandrol A Exhibits Estrogenic Activity via Estrogen Receptor α-Dependent Signaling Pathway in Estrogen Receptor-Positive Breast Cancer Cells
por: Lee, Dahae, et al.
Publicado: (2021) -
Estrogen receptor positive breast cancers and their association with environmental factors
por: St-Hilaire, Sophie, et al.
Publicado: (2011) -
Genes Dysregulated to Different Extent or Oppositely in Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancers
por: Zhou, Xianxiao, et al.
Publicado: (2013) -
Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer
por: Simigdala, Nikiana, et al.
Publicado: (2016) -
Expression of Androgen Receptor in Estrogen Receptor–positive Breast Cancer
por: Agrawal, Anil, et al.
Publicado: (2016)